Augmedix

AUGX61

Penny Stock

$2.330.00%$0.00

Penny Stock

AUGX61

$2.33

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$2.33
Prev. Close	$2.33
EPS	-0.47
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$115.41M
PE Ratio	-

	LOW	HIGH
Day Range	2.33	2.34
52 Week Range	0.73	6.25

Ratios







EPS	-0.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Augmedix (AUGX)

Augmedix, Inc. (AUGX) is a healthcare technology company that specializes in providing remote medical documentation services using augmented reality technology. The company's stock price history shows a steady growth over the past few years, as the demand for telemedicine solutions has increased. AUGX's stock has experienced some fluctuations, but overall, it has performed well in the market.

In terms of the company's quote, AUGX is currently trading at a favorable price. Investors are optimistic about the future prospects of Augmedix, Inc. and its innovative approach to healthcare. The stock news for AUGX has been positive, with the company receiving recognition for its advancements in telemedicine and augmented reality technologies. This has further boosted investor confidence in AUGX.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Mr. Emmanuel Krakaris
Headquarters: San Francisco
Employees: 1040
Exchange: NASDAQ

Keep an eye on Augmedix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Augmedix's (AUGX) price per share?

The current price per share for Augmedix (AUGX) is $2.33. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Augmedix (AUGX)?

For Augmedix (AUGX), the 52-week high is $6.25, which is 168.24% from the current price. The 52-week low is $0.73, the current price is 219.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Augmedix (AUGX) a growth stock?

Augmedix (AUGX) has shown an average price growth of 0.41% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Augmedix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Augmedix (AUGX) stock price performance year to date (YTD)?

As of the latest data, Augmedix (AUGX) has a year-to-date price change of -60.03%. Over the past month, the stock has experienced a price change of 1.75%. Over the last three months, the change has been 202.32%. Over the past six months, the figure is -30.03%.

help

Is Augmedix (AUGX) a profitable company?

Augmedix (AUGX) has a net income of -$19.17M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 47.99% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -63.85% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $44.86M, with a revenue growth rate of 45.01%, providing insight into the company's sales performance and growth. The gross profit is $21.53M. Operating income is noted at -$18.78M. Furthermore, the EBITDA is -$22.47M.

help

What is the market capitalization of Augmedix (AUGX)?

Augmedix (AUGX) has a market capitalization of $115.41M. The average daily trading volume is 63.2K, indicating the stock's liquidity and investor engagement.

News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders

VECTOR GROUP LTD.

CONNECTONE BANCORP, INC.

AUGMEDIX, INC.

MERGERS AND ACQUISITIONS

SHAREHOLDER RIGHTS

9/12/2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, FLIC, GATO, AUGX on Behalf of Shareholders

FRONTIER COMMUNICATIONS PARENT, INC.

THE FIRST OF LONG ISLAND CORPORATION

GATOS SILVER, INC.

AUGMEDIX, INC.

SHAREHOLDER INVESTIGATION

SECURITIES LAWS

FIDUCIARY DUTIES

9/7/2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, FLIC, GATO, AUGX on Behalf of Shareholders

Artificial Intelligence (AI) in Healthcare Research Report 2024: Market to Reach $153.61 Billion by 2029, Growing at a Staggering CAGR of 48.49% - Emergence of New AI Startups, Rising Automation